Tackling Specialty Conditions and Side Effects Simultaneously
Carol Huynh, a practicing clinical pharmacist and manager of clinical outcomes at Shields Health Solutions, a specialty pharmacy accelerator, dissects the ways to address undertreated side effects that can form as a result of having a specialty condition, including the use of an adapted care model.
13m Sep 30, 2022
13m
The Co-existence of Commercialization and Patient Support
Innes Meldrum, SVP and chief commercial officer at Otsuka Pharmaceuticals US, discusses the bottlenecks that can arise during the product commercialization process, the value of patient education, and how he envisions the future of both ideas shaping up.
21m Sep 16, 2022
21m
Lowering Lead Times, Controlling Costs, Retaining Talent
Vincent Colicchio, vice president of supply chain and external manufacturing at Dr. Reddy's Laboratories, reviews the key supply chain advances in the course of his career and reflects on the particular demands of the COVID pandemic.
19m Sep 02, 2022
19m
Understanding the Patient Journey in Complex and Rare Diseases
Ushank Agarwal, vice president of commercial operations at HUTCHMED, a company developing targeted therapies for cancer and immunological diseases, talks about the importance of monitoring the patient journey in the complex and rare diseases space, and how to get the best out of data in this area.
10m Aug 19, 2022
10m
Intertwining Technology and Data Solutions
Michael Swartz, SVP of Enterprise Product Strategy for Dotmatics, an R&D scientific software company, discusses the impact that the “data deluge” is having on biopharma companies, along with what the “lab of the future” shapes up to be in his eyes.
17m Aug 05, 2022
17m
Making the Commercialization Process Worthwhile
Diana Villanova, VP of patient services & channel strategy at COEUS Consulting Group, a full-service market access firm, dives into the importance of patient support programs—including the value in stepping outside one’s comfort zone—along with how drug producers can use patient and channel strategies to maximize payoff.
14m Jul 22, 2022
14m
Addressing Rising Rx Costs
Nelly Rose, PharmD, VP of clinical consulting for NFP, an insurance broker and consultant that provides solutions to clients that span numerous industries, addresses the increase in prescription drug spending, along with ways to find more affordable options for driving down pharmacy spend, including the impact of biosimilars in the marketplace.
18m Jul 08, 2022
18m
Prioritizing American Manufacturing
David Sanders, vice president of government affairs & policy at biosimilars company Coherus BioSciences, speaks on the firm’s goal of expanding patient access to cost-effective medication, and his role with Securing America’s Medicines and Supply, a coalition of companies aiming to strengthen the security of the US medical supply chain.
14m May 13, 2022
14m
Re-evaluating the Role of the Pharmacist
Dennis Wright, senior director of product marketing at Omnicell, a company that provides both a medication management platform along with technology-enabled services, discusses the ongoing issue of medication nonadherence and efficient ways to utilize pharmacists’ expertise in an effort to create an effective supply chain.
11m Apr 29, 2022
11m
Providing Medication Access to Africa
Adham Yehia, co-founder and COO of DrugStoc, a cloud-based pharmaceutical distribution platform that is working to assist healthcare providers (HCPs) across Africa by connecting manufacturers to hospitals and pharmacies, outlines his inspiration for founding the company, along with the logistical obstacles that come with distribution.
24m Apr 15, 2022
24m
Advancing Pharmacovigilance
Glenn Carroll, safety leader and principal at Deloitte Consulting, a firm that has collaborated with a Big Pharma company on an AI software-as-a-service platform, details the obstacles that drug safety providers face today, and how the competitive landscape is evolving as new entrants join the field.
20m Apr 01, 2022
20m
Promoting Effective Patient Support
Sandra Anderson, senior vice president of commercialization and strategy at Innomar Strategies, a service provider in the Canadian specialty biopharma space, discusses the process in bringing a product to market in Canada, how Innomar guides patients along their patient journey, the logistical challenges that come with vaccine distribution, and plenty more.
20m Mar 18, 2022
20m
Enhancing Conversational AI
Patty Riskind, CEO of Orbita, discusses the origins of the platform, her inspiration in joining the team, how in fact the company uses conversational artificial intelligence (AI) to its advantage and the future outlook of this technology.
21m Mar 04, 2022
21m
Seeking Better Patient Engagement
Ardy Arianpour, the outspoken CEO and co-founder of health-tech company Seqster, details his personal motivation and entrepreneurial quest to topple data-access barriers in digital health, the chance meeting with Bill Gates that helped shape his platform's mission and explains the concept of “person-centric interoperability” in transforming “real-time” efforts in patient engagement.
23m Feb 18, 2022
23m
RWD ‘Fitness’ Steps for Pharma
Matthew W. Reynolds, vice president, real-world solutions, at IQVIA, dives into the implications of FDA’s recent draft guidance on using real-world data from electronic health records and medical claims data to aid in drug development and regulatory decision-making—and shares specific steps pharma companies can take to assess the relevance and quality of their data in light of this guidance.
25m Feb 04, 2022
25m
M&A Milestones: The Covid Impact
Casey McTigue, managing director of professional services at SRS Acquiom, which provides support for M&A transactions across various sectors, discusses the firm’s recently released study on milestone payment and earnout trends in life sciences M&A, including during Covid; their influence on sales and development milestones; how parties account for transaction disputes; and the potentially shift...
17m Jan 21, 2022
17m
Solving the Drug Pricing Conundrum
AJ Loiacono, CEO of Capital Rx, which doubles as pharmacy benefit manager (PBM)and health tech firm, dives into his inspiration for entering the PBM arena, the company’s formula for providing more transparency into drug pricing and the importance of simplifying complex administrative and workflow barriers between pharmacies, payers and other entities to keep up with the future of healthcare.
28m Jan 07, 2022
28m
Diversity and Disruption in Clinical Research
David Coman, CEO of Science 37, a decentralized clinical trials platform company, discusses his organization’s recent public debut via the SPAC route, how that’s powering its mission to enable universal and diverse access to clinical research, and the potential of “agile clinical trial” designs in disrupting the future drug development landscape for the better.
26m Dec 17, 2021
26m
Diagnostic Testing During a Pandemic
Pouria Sanae, CEO of ixlayer, a technology company, explains the obstacles surrounding the distribution of remote lab tests pre-, during and post-pandemic, the shift to at-home Covid screenings, the logistical challenges in collaborating with different US regions, and the concept of the “pre-patient” model for preventative care.
25m Dec 01, 2021
25m
A Check-in with Chip Davis
The PC Podcast catches up with Chip Davis, president and CEO of the Healthcare Distribution Alliance (HDA), who shares candid perspectives on the role of pharmaceutical distributors during the pandemic, how HDA members are navigating today’s wider supply-chain disruption and the latest actions from the sector in achieving critical sustainability goals.
23m Nov 16, 2021
23m
Democratizing Reproductive Treatments for All
Brent Ragans, president of Ferring Pharmaceuticals US, a specialty biopharmaceutical company involved in various treatment areas, including reproductive medicine and maternal health, explores the stigma surrounding infertility, the challenge of improving patient access to IVF treatment and care, and legislative developments addressing hopeful health coverage and eligibility reform in this area.
22m Oct 29, 2021
22m
The Pursuit of Precision in Point-of-Care Support
Chris DiCostanzo, VP of patient engagement solutions for OptimizeRx, a provider of digital health tools and strategies to improve drug affordability and adherence, discusses the challenges encountered most today in therapy initiation and maintaining treatment—and how new approaches in brand communication and messaging, including the use of AI-driven real-world evidence, can deliver benefits to ...
21m Oct 15, 2021
21m
Enterprise Podcasting in Pharma
Jen Grogono, founder and CEO of uStudio, which works with pharma companies to streamline information, updates and training for their sales professionals, discusses the challenges for drugmakers in keeping employees in the know—and how the use of adaptive communication models like enterprise, or internal, podcasting can help connect company culture and address the changing messaging needs of inc...
19m Oct 01, 2021
19m
Vision and Visibility: RFID’s Emergence in Healthcare
Tim Kress-Spatz, president at DoseID Consortium, an industry group established to unify an approach to serialized, radio-frequency identification (RFID) pharmaceutical products, and co-founder of Kit Check, which helps provide visibility into medication supply management, discusses RFID’s promise in downstream supply-chain tracking, the importance of interoperability in tracing drugs, reducing ...
23m Aug 27, 2021
23m
Managing Revenue in a Tech-driven World
Mike Townsend, research director of life sciences commercial strategies at the International Data Corporation (IDC), a global provider of market intelligence, advisory services and events for various sectors, discusses how revenue management is influenced by factors such as industry reputation, advances in cloud technology and data analytics, the complex drug coverage picture, new supply chain ...
21m Jul 29, 2021
21m
Predicting Supply Risk and Disruption
Atul Vashishta, founder and CEO of Supply Wisdom, a company that delivers continuous risk intelligence, discusses his story in starting up the business, how he identified early risk indicators for Covid disruption, industry approaches to cybersecurity and plenty more.
28m Jun 24, 2021
28m
Living and Leading the Patient Experience
Dave Fuehrer, cofounder and CEO of GRYT Health, a digital healthcare company that provides patient research support educational services focused in the oncology space, discusses his story, the challenges in setting up GRYT Health’s business model, its use of technology to enhance the patient experience and much more.
17m May 20, 2021
17m